Progressive supranuclear palsy syndrome induced by clebopride.
Identifieur interne : 003478 ( PubMed/Corpus ); précédent : 003477; suivant : 003479Progressive supranuclear palsy syndrome induced by clebopride.
Auteurs : Jaume Campdelacreu ; Hatice Kumru ; Eduard Tolosa ; Josep Valls-Solé ; Antoni BenabarreSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2004.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antiemetics, Benzamides.
- chemically induced : Supranuclear Palsy, Progressive.
- diagnosis : Supranuclear Palsy, Progressive.
- Female, Humans, Middle Aged.
Abstract
We report on a patient who presented with a progressive supranuclear palsy (PSP) syndrome while receiving clebopride (CLB), a prokinetic drug with central antidopaminergic properties. The clinical and neurophysiological signs progressively disappeared after CLB withdrawal. To our knowledge, this is the first published PSP-like syndrome attributable to an antidopaminergic drug.
DOI: 10.1002/mds.10692
PubMed: 15077251
Links to Exploration step
pubmed:15077251Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Progressive supranuclear palsy syndrome induced by clebopride.</title>
<author><name sortKey="Campdelacreu, Jaume" sort="Campdelacreu, Jaume" uniqKey="Campdelacreu J" first="Jaume" last="Campdelacreu">Jaume Campdelacreu</name>
<affiliation><nlm:affiliation>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kumru, Hatice" sort="Kumru, Hatice" uniqKey="Kumru H" first="Hatice" last="Kumru">Hatice Kumru</name>
</author>
<author><name sortKey="Tolosa, Eduard" sort="Tolosa, Eduard" uniqKey="Tolosa E" first="Eduard" last="Tolosa">Eduard Tolosa</name>
</author>
<author><name sortKey="Valls Sole, Josep" sort="Valls Sole, Josep" uniqKey="Valls Sole J" first="Josep" last="Valls-Solé">Josep Valls-Solé</name>
</author>
<author><name sortKey="Benabarre, Antoni" sort="Benabarre, Antoni" uniqKey="Benabarre A" first="Antoni" last="Benabarre">Antoni Benabarre</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15077251</idno>
<idno type="pmid">15077251</idno>
<idno type="doi">10.1002/mds.10692</idno>
<idno type="wicri:Area/PubMed/Corpus">003478</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Progressive supranuclear palsy syndrome induced by clebopride.</title>
<author><name sortKey="Campdelacreu, Jaume" sort="Campdelacreu, Jaume" uniqKey="Campdelacreu J" first="Jaume" last="Campdelacreu">Jaume Campdelacreu</name>
<affiliation><nlm:affiliation>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kumru, Hatice" sort="Kumru, Hatice" uniqKey="Kumru H" first="Hatice" last="Kumru">Hatice Kumru</name>
</author>
<author><name sortKey="Tolosa, Eduard" sort="Tolosa, Eduard" uniqKey="Tolosa E" first="Eduard" last="Tolosa">Eduard Tolosa</name>
</author>
<author><name sortKey="Valls Sole, Josep" sort="Valls Sole, Josep" uniqKey="Valls Sole J" first="Josep" last="Valls-Solé">Josep Valls-Solé</name>
</author>
<author><name sortKey="Benabarre, Antoni" sort="Benabarre, Antoni" uniqKey="Benabarre A" first="Antoni" last="Benabarre">Antoni Benabarre</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiemetics (adverse effects)</term>
<term>Benzamides (adverse effects)</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Supranuclear Palsy, Progressive (chemically induced)</term>
<term>Supranuclear Palsy, Progressive (diagnosis)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiemetics</term>
<term>Benzamides</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report on a patient who presented with a progressive supranuclear palsy (PSP) syndrome while receiving clebopride (CLB), a prokinetic drug with central antidopaminergic properties. The clinical and neurophysiological signs progressively disappeared after CLB withdrawal. To our knowledge, this is the first published PSP-like syndrome attributable to an antidopaminergic drug.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">15077251</PMID>
<DateCreated><Year>2004</Year>
<Month>04</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted><Year>2004</Year>
<Month>08</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>19</Volume>
<Issue>4</Issue>
<PubDate><Year>2004</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Progressive supranuclear palsy syndrome induced by clebopride.</ArticleTitle>
<Pagination><MedlinePgn>482-4</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We report on a patient who presented with a progressive supranuclear palsy (PSP) syndrome while receiving clebopride (CLB), a prokinetic drug with central antidopaminergic properties. The clinical and neurophysiological signs progressively disappeared after CLB withdrawal. To our knowledge, this is the first published PSP-like syndrome attributable to an antidopaminergic drug.</AbstractText>
<CopyrightInformation>Copyright 2003 Movement Disorder Society</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campdelacreu</LastName>
<ForeName>Jaume</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kumru</LastName>
<ForeName>Hatice</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tolosa</LastName>
<ForeName>Eduard</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Valls-Solé</LastName>
<ForeName>Josep</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Benabarre</LastName>
<ForeName>Antoni</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000932">Antiemetics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001549">Benzamides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>55905-53-8</RegistryNumber>
<NameOfSubstance UI="C014417">clebopride</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000932">Antiemetics</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001549">Benzamides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013494">Supranuclear Palsy, Progressive</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>4</Month>
<Day>13</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>8</Month>
<Day>6</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>4</Month>
<Day>13</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15077251</ArticleId>
<ArticleId IdType="doi">10.1002/mds.10692</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003478 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003478 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:15077251 |texte= Progressive supranuclear palsy syndrome induced by clebopride. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15077251" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |